Pluralsight Inc Cl A (PS)

22.45  +0.03 (+0.13%)

After market: 22.45 0 (0%)

News Image
10 months ago - Lendio, Inc.

Lendio Adds Heather Zynczak to its Board of Directors

/PRNewswire/ -- Lendio, the nation's leading small business financial solutions platform, announces today the appointment of Heather Zynczak to its board of...

News Image
a year ago - D2L Inc.

D2L Inc. Appoints Heather Zynczak to Board of Directors

/CNW/ - D2L Inc. (TSX: DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive...

News Image
3 years ago - Market News Video

First Week of PS July 16th Options Trading

Investors in Pluralsight Inc (PS) saw new options begin trading this week, for the July 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 123 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

News Image
3 years ago - Capital Market Laboratories

Technical Short Put Spread Fade the Dip Trade and Trigger in Pluralsight Inc

The Techncial Trigger Driven Option Trade Right Before Pluralsight Inc (NASDAQ:PS) Earnings.

News Image
3 years ago - Pluralsight, Inc.

Pluralsight Comments on ISS Report

News Image
3 years ago - BusinessInsider

Pluralsight Announces Fourth Quarter 2020 Results

SILICON SLOPES, Utah, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pluralsight, Inc. (NASDAQ: PS), the technology workforce development company, today anno...

News Image
3 years ago - Halper Sadeh LLP

INVESTIGATION ALERT: Halper Sadeh LLP Investigates VIE, BPFH, SMTX, PS; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / February 9, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Viela Bio, Inc. (NASDAQ:VIE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Horizon Therapeutics plc for $53.00 per share in cash. If you are a Viela Bio shareholder, click here to learn more about your rights and

News Image
3 years ago - Pluralsight, Inc.

Pluralsight Files Investor Presentation in Connection with Proposed Transaction with Vista Equity Partners

Urges Shareholders to Vote “FOR” Transaction Ahead of Special Meeting of Shareholders on March 2, 2021

News Image
3 years ago - CNBC

Microsoft beefs up Teams with learning tools as companies prepare to reopen offices

Microsoft Viva can infuse the Teams app with learning materials, internal announcements, an encyclopedia of corporate terms and tools for avoiding burnout.